Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.94−0.26 (-4.19%)
Close on Nov 18, 2026Market cap $91.83MP/E –Yield –
Satellos Bioscience net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Satellos Bioscience
Satellos Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?